Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Deep Value
  3. /Seeds/Tissue Culture/Bio Technology
  4. /Rossari Biotech Ltd
MomentumDeep Value

Rossari Biotech Ltd: Is It a Deep Value Opportunity?

AverageSteady Growth

As of May 2, 2026, Rossari Biotech Ltd (Seeds/Tissue Culture/Bio Technology) has a deep value score of 41/100 (rated Average). Earnings are accelerating. 1Y return vs Nifty 500: -30%.

Rossari Biotech Ltd Key Facts

PE Ratio
17.8x
Market Cap
₹2,653 Cr
Value Score
41/100
PAT Growth YoY
+35%
Revenue Growth YoY
+18%
OPM
11.0%
PE: Cycle BottomStrong Opportunity

What's Happening

💎PE falling while earnings hold — value emerging
💪Debt reduced 19% YoY — balance sheet strengthening
🌐FII stake decreased 1.0% this quarter

Key Numbers

PAT Growth YoY
+35%
Inflection Up
Revenue YoY
+18%
Stable
Operating Margin
11.0%
-100 bps YoY
PE Ratio
17.8
PEG Ratio
1.34
Current Price
₹479
Dividend Yield
0.10%
3Y PAT CAGR
+12%
Market Cap
2.7K Cr
Valuation
N/A

How Fast Is Rossari Biotech Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue+18%+13%Stable
PAT (Net Profit)+35%+12%Inflection Up
OPM11.0%-100 bpsContracting
← Back to Seeds/Tissue Culture/Bio TechnologyAll Deep Value SectorsDashboard

Frequently Asked Questions: Rossari Biotech Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What is Rossari Biotech Ltd's deep value score?

Rossari Biotech Ltd has a deep value score of 41/100 (rated Average). This score is calculated from three components

  • Earnings Score: 21/40 — measures PAT growth momentum across quarters
  • Underperformance Score: 17/35 — how much the stock trails Nifty 500 (deeper underperformance = higher contrarian signal)
  • Quality Score: 6/25 — operational quality (margins, revenue growth, valuation)

Is Rossari Biotech Ltd fundamentally improving?

Rossari Biotech Ltd's quarterly profit (PAT) growth trajectory

  • Latest Quarter PAT Growth (QoQ): +40%
  • Previous Quarter PAT Growth (QoQ): -11%
  • 2 Quarters Ago PAT Growth (QoQ): +10%
  • PAT Acceleration: +15.3pp (profits are accelerating)
  • 1 consecutive quarters of positive PAT growth

Why is Rossari Biotech Ltd underperforming despite good earnings?

Rossari Biotech Ltd is underperforming the market despite improving earnings — this is the core deep value thesis

  • 1-Year Return vs Nifty 500: -30%
  • 6-Month Return vs Nifty 500: -21%
  • 3-Month Return vs Nifty 500: -13%
  • Yet average quarterly PAT growth is +13% — earnings are improving
  • The market often takes time to re-rate stocks with improving fundamentals. This gap between price performance and earnings improvement is what deep value research seeks to identify.

What is the earnings momentum for Rossari Biotech Ltd?

Rossari Biotech Ltd's earnings momentum is Steady — consistent growth.

  • PAT QoQ progression: +10% → -11% → +40% (2Q ago → 1Q ago → latest)
  • Acceleration: +15.3pp
  • PAT YoY Growth: +35%

Is Rossari Biotech Ltd undervalued?

Rossari Biotech Ltd's valuation metrics

  • Price-to-Earnings (PE): 17.8x
  • Price-to-Book (PB): 2.0x
  • PEG Ratio: 1.3x

What are the revenue and margin trends for Rossari Biotech Ltd?

Rossari Biotech Ltd's revenue and margin trends

  • Latest Quarter Revenue Growth (QoQ): +18%
  • Average Quarterly Revenue Growth: +8%
  • Revenue Acceleration: +5.0pp
  • Latest OPM Change: -0.6pp (margins contracting)
  • Average OPM Change: -0.4pp
  • Revenue YoY: +18%

What is Rossari Biotech Ltd's trailing twelve month (TTM) performance?

Rossari Biotech Ltd's trailing twelve month (TTM) performance

  • TTM PAT: ₹150 Cr
  • TTM PAT Growth: +10.3% YoY
  • TTM Revenue: ₹2,000 Cr
  • TTM Revenue Growth: +15.2% YoY
  • TTM Operating Margin: 11.7%

What sector does Rossari Biotech Ltd belong to?

Rossari Biotech Ltd key facts

  • Sector: Seeds/Tissue Culture/Bio Technology
  • Market Cap: ₹2.7K Cr
  • Rank in Seeds/Tissue Culture/Bio Technology: #1 by value score
  • Overall rank among all deep value stocks: #53

Is Rossari Biotech Ltd a good deep value opportunity to study?

Rossari Biotech Ltd shows limited deep value signals currently — score is 41/100 (Average). Monitor for improvement.

  • Value Score: 41/100 (Average)
  • Earnings: Accelerating
  • 1Y Underperformance: -30% vs Nifty 500

What is the bull and bear case for Rossari Biotech Ltd?

Research Signals (Bull Case)

  • Earnings accelerating — profit growth speeding up
  • Revenue growth also accelerating

Risk Factors (Bear Case)

  • Significant underperformance (-30% vs Nifty 1Y)
  • Margin pressure warning
  • Operating margins contracting

How does the Seeds/Tissue Culture/Bio Technology sector look for deep value?

Seeds/Tissue Culture/Bio Technology deep value sector overview

  • 1 deep value stocks in this sector
  • Average value score: 41/100
  • Avg PAT acceleration: +15.3pp
  • Top pick: Rossari Biotech Ltd

What is deep value investing?

Deep value investing studies stocks that are underperforming the market despite showing improving fundamentals. The thesis is that the market has not yet recognized the earnings recovery, creating a potential valuation gap. It requires patience — recovery can take several quarters.

How is the deep value score calculated?

The deep value score (0-100) combines three factors:

- Earnings (0-40 pts): PAT growth across last 3 quarters, acceleration, and consecutive growth - Underperformance (0-35 pts): How much the stock trails Nifty 500 over 1Y, 6M, 3M (deeper underperformance = higher score) - Quality (0-25 pts): Revenue growth, margin trends, and valuation metrics (PEG, P/B)

Higher score indicates a stronger contrarian research signal.

The above FAQs are generated from publicly available earnings data. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.